Prognostic Impact of LKB1 Expression in Advanced Non-Small-Cell Lung Cancer

被引：1
|
作者：
Diaz-Garcia, D. A. [1 ]
Ramirez Tirado, L. A. [2 ]
Aviles-Salas, A. [2 ]
Cardona, A. F. [3 ]
Rodriguez-Rios, A. [2 ]
Barron, F. [1 ]
Arrieta, O. G. [1 ]
机构：
[1] Inst Nacl Cancerol, Thorac Oncol Unit, Mexico City, DF, Mexico
[2] Inst Nacl Cancerol Incan, Mexico City, DF, Mexico
[3] Ficmac Fdn Invest Clin & Mol Aplicada Canc, Med Oncol, Bogota, Colombia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
LKB1; NSCLC; biomarkers;
D O I：
10.1016/j.jtho.2019.08.1677
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.09-28
引用
收藏
页码：S780 / S781
页数：2
相关论文
共 50 条
  • [1] LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer
    Aviles-Salas, Alejandro
    Diaz-Garcia, Diego A. A.
    Lara-Mejia, Luis
    Cardona, Andres F.
    Orozco-Morales, Mario
    Catalan, Rodrigo
    Hernandez-Pedro, Norma Y. Y.
    Rios-Garcia, Eduardo
    Ramos-Ramirez, Maritza
    Arrieta, Oscar
    CURRENT ONCOLOGY, 2023, 30 (01) : 333 - 343
  • [2] LKB1/AMPK/mTOR Signaling Pathway in Non-small-cell Lung Cancer
    Han, Dong
    Li, Shao-Jun
    Zhu, Yan-Ting
    Liu, Lu
    Li, Man-Xiang
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (07) : 4033 - 4039
  • [3] Impact of LKB1 status on radiation outcome in patients with stage III non-small-cell lung cancer
    Sitthideatphaiboon, Piyada
    Nantavithya, Chonnipa
    Chantranuwat, Poonchavist
    Vinayanuwattikun, Chanida
    Sriuranpong, Virote
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [4] Impact of LKB1 status on radiation outcome in patients with stage III non-small-cell lung cancer
    Piyada Sitthideatphaiboon
    Chonnipa Nantavithya
    Poonchavist Chantranuwat
    Chanida Vinayanuwattikun
    Virote Sriuranpong
    Scientific Reports, 14
  • [5] STK11/LKB1 mutation in non-small cell lung cancer: Prognostic or predictive?
    Rosellini, P.
    Girodet, P. O.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 50 - 51
  • [6] LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab
    Bonanno, Laura
    De Paoli, Angela
    Zulato, Elisabetta
    Esposito, Giovanni
    Calabrese, Fiorella
    Favaretto, Adolfo
    Santo, Antonio
    Del Conte, Alessandro
    Chilosi, Marco
    Oniga, Francesco
    Sozzi, Gabriella
    Moro, Massimo
    Ciccarese, Francesco
    Nardo, Giorgia
    Bertorelle, Roberta
    Candiotto, Cinzia
    De Salvo, Gian Luca
    Amadori, Alberto
    Conte, PierFranco
    Indraccolo, Stefano
    CLINICAL CANCER RESEARCH, 2017, 23 (13) : 3316 - 3324
  • [7] PREDICTIVE VALUE OF LKB1 IN PATIENTS WITH RESECTED NON SMALL CELL LUNG CANCER
    Fabre, E.
    Pecuchet, N.
    Laurent-Puig, P.
    Pallier, K.
    Le Pimpec-Barthes, F.
    Riquet, M.
    Cazes, A.
    Blons, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 77 - 77
  • [8] Prognostic factors of advanced stage non-small-cell lung cancer
    Kwas, H.
    Guermazi, E.
    Khattab, A.
    Hrizi, C.
    Zendah, I.
    Ghedira, H.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2017, 73 (04) : 180 - 187
  • [9] LKB1 Mutations in Metastatic Non-Small Cell Lung Cancer (mNSCLC): Prognostic Value in the Real World
    Golozar, A.
    Collins, J.
    Fraeman, K.
    Nordstrom, B.
    Mcewen, R.
    Shire, N.
    Higgs, B.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S223 - S224
  • [10] PROGNOSTIC IMPACT OF CANCER CACHEXIA IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER RECEIVING CHEMOTHERAPY
    Kimura, Madoka
    Naito, Tateaki
    Wakuda, Kazushige
    Oyakawa, Takuya
    Hisamatsu, Yasushi
    Imai, Hisao
    Tokito, Takaaki
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Shukuya, Takehito
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Endo, Masahiro
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S490 - S490
12345